Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PDZ and pleckstrin homology domains 1, pseudogene (PDZPH1P), is a presumed non-protein-coding sequence classified as a pseudogene; it shows similarity to genes encoding proteins with PDZ and pleckstrin homology domains, which are important for scaffold and signaling functions, but PDZPH1P itself is not known to produce a functional protein and is not considered a therapeutic target[4]. Pseudogenes are genomic sequences similar to known genes but are typically non-functional due to mutations or lack of expression; they do not usually code for functional proteins and are not classified in standard therapeutic target categories. PDZ domain-containing proteins as a family have biological functions in cell signaling and are associated with certain diseases, but PDZPH1P does not fall into this category as a functional gene[2][4]. There are no drugs, mechanisms of action, or safety data relevant to this pseudogene. PDZPH1P is not a receptor, enzyme, transporter, or recognized therapeutic target; it is a pseudogene lacking evidence of biological or pharmacological relevance as a molecular target[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PDZ and pleckstrin homology domains 1, pseudogene (PDZPH1P).